These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6685632)

  • 21. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
    Monsma FJ; Katzenellenbogen BS; Miller MA; Ziegler YS; Katzenellenbogen JA
    Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK; Ruh MF; Butler WB; Ruh TS
    Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity of estradiol mustard for estrogen receptors and its enzymatic degradation in uterine and breast cancer cytosols.
    Leclercq G; Deboel MC; Heuson JC
    Int J Cancer; 1976 Dec; 18(6):750-6. PubMed ID: 992905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations.
    Shafie S; Brooks SC
    J Lab Clin Med; 1979 Nov; 94(5):784-98. PubMed ID: 501205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E; Borgna JL; Rochefort H
    Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M; Greene G; Rochefort H; Jensen EV
    Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
    Poulin R; Merand Y; Poirier D; Levesque C; Dufour JM; Labrie F
    Breast Cancer Res Treat; 1989 Oct; 14(1):65-76. PubMed ID: 2605344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear [3H]4-hydroxytamoxifen (4-OHTAM)- and [3H]estradiol (E2)-estrogen receptor complexes in the MCF-7 breast cancer and GH3 pituitary tumor cell lines.
    Tate AC; Jordan VC
    Mol Cell Endocrinol; 1984 Jul; 36(3):211-9. PubMed ID: 6468749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Displacement by tamoxifen of the estradiol-estrogen receptor binding: a functional assay for breast cancer studies.
    Levin E; Tomchinsky S; López S
    J Steroid Biochem Mol Biol; 1990 Dec; 37(5):681-6. PubMed ID: 2278851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.
    Martel C; Provencher L; Li X; St Pierre A; Leblanc G; Gauthier S; Mérand Y; Labrie F
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):199-205. PubMed ID: 9605415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor assay of mammary carcinomas. Effects of testosterone-estradiol-binding globulin (TeBG) and serum estradiol-17 beta.
    Meyer JS; Stevens SC; Vandillen N; White WL
    Am J Clin Pathol; 1979 Oct; 72(4):564-70. PubMed ID: 573965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High affinity cytosol binding site(s) for antiestrogens in two human breast cancer cell lines and in biopsy specimens devoid of estrogen receptors.
    Chouvet C; Saez S
    J Steroid Biochem; 1984 Dec; 21(6):755-61. PubMed ID: 6527539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells--relationship between processing and estrogenicity.
    Gyling M; Leclercq G
    J Steroid Biochem; 1988 Jan; 29(1):1-8. PubMed ID: 3347042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptors in rat bone: their interaction with estrogen receptor modulators.
    Pal R; Chaturvedi R; Kamboj KK; Chowdhury SR; Dwivedi A
    Endocr Res; 2001 Aug; 27(3):283-91. PubMed ID: 11678575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment.
    Leclercq G; Legros N; Piccart MJ
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):545-52. PubMed ID: 1562525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of [3H] monohydroxytamoxifen in human breast carcinoma cytosols.
    Jordan VC; Fischer AH; Rose DP
    Eur J Cancer (1965); 1981 Jan; 17(1):121-2. PubMed ID: 7262143
    [No Abstract]   [Full Text] [Related]  

  • 38. Exchange of bound estrogens and antiestrogens in MCF-7 cells: evidence for ligand-induced stable configurations of the estrogen receptor.
    El khissiin A; Leclercq G
    Steroids; 1998 Nov; 63(11):565-74. PubMed ID: 9830682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.